NCT00002439
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +19 more
- Locations
-
Not specified
Clinical trial condition
Neoplasms, Vascular Tissue
Explore clinical trials studying Neoplasms, Vascular Tissue. Study availability and eligibility vary by location and protocol.
490 public trials
108 recruiting studies
Neoplasms, Vascular Tissue trial results
Active, Not Recruiting
Radiological Diagnosis of Pediatric Neck Swellings
NCT07734805
- Conditions
- Branchial Cleft Anomalies, Branchioma, Chondrosarcoma, Extraskeletal Myxoid, +24 more
- Locations
-
- Faculty of Medicine Sohag University Sohag, Sohag Governorate, Egypt
Active, Not Recruiting
Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease
NCT00005902
- Conditions
- Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +18 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors
NCT03220646
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
- Locations
-
- Hartford Healthcare Cancer Institute @ Hartford Hospital (Data collection only) Hartford, Connecticut, United States
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
Active, Not Recruiting
An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma
NCT02648997
- Conditions
- Central Nervous System Neoplasms, Meningeal Neoplasms, Meningioma, +8 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI
NCT04638478
- Conditions
- Central Nervous System Neoplasms, Meningeal Neoplasms, Meningioma, +7 more
- Locations
-
- Maastricht Radiation Oncology Maastricht, Limburg, Netherlands
Active, Not Recruiting
Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma
NCT01892397
- Conditions
- Brain Cancer, Brain Diseases, Brain Neoplasms, +11 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of Colorado Denver, Colorado, United States
- University of Miami Miami, Florida, United States
- Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
Active, Not Recruiting
Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma
NCT04668300
- Conditions
- Hemangiosarcoma, Liposarcoma, Metastatic Angiosarcoma, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma
NCT03279692
- Conditions
- Central Nervous System Neoplasms, High Grade Meningioma, Meningeal Neoplasms, +8 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States